• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T cell stimulation via CD47: agonistic and antagonistic effects of CD47 monoclonal antibody 1/1A4.

作者信息

Waclavicek M, Majdic O, Stulnig T, Berger M, Baumruker T, Knapp W, Pickl W F

机构信息

Institute of Immunology, University of Vienna, Austria.

出版信息

J Immunol. 1997 Dec 1;159(11):5345-54.

PMID:9548474
Abstract

CD47/integrin-associated protein has been extensively studied on various cell types. The function of CD47 on T cells, however, remained poorly understood. We demonstrate here that our CD47 mAb 1/1A4 has both inhibitory as well as costimulatory effects in terms of T cell activation. Soluble, not cross-linked, CD47 mAb 1/1A4 blocks allogeneic MLRs. This effect is predominantly observed with suboptimal numbers of stimulator cells. In contrast, cross-linking of CD47 in the presence of CD28 mAb or phorbol ester induces vigorous T cell proliferation that is sensitive to cyclosporin A. Cross-linking, but not immobilization, of the CD47 mAb 1/1A4 is an essential requirement for the CD28- or phorbol ester-dependent induction of T cell mitogenesis. Furthermore, CD47 mAb 1/1A4 induces T cell proliferation when coimmobilized with a CD3 mAb to the same surface. Ligation with cross-linked 1/1A4 mAb induces an increase in intracellular free calcium levels and leads to tyrosine phosphorylation of various cellular proteins and, in the presence of suboptimal concentrations of plate-bound CD3 mAb, to enhanced IL-2 promotor activity in T cells. Furthermore, we present evidence that upon cross-linking of CD47 with mAb 1/1A4, purified T cells acquire responsiveness for several T cell growth factors. IL-1beta and/or IL-6 dramatically augment this CD47-induced cytokine responsiveness. Our results suggest that the novel activation pathway via CD47 might be critically involved in Ag-dependent and Ag-independent T cell functions.

摘要

相似文献

1
T cell stimulation via CD47: agonistic and antagonistic effects of CD47 monoclonal antibody 1/1A4.
J Immunol. 1997 Dec 1;159(11):5345-54.
2
Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells.整合素相关蛋白(CD47)是CD3激活的人T细胞上的一种协同有丝分裂分子。
J Immunol. 1997 Jan 15;158(2):677-84.
3
CD47 signals T cell death.CD47信号传导导致T细胞死亡。
J Immunol. 1999 Jun 15;162(12):7031-40.
4
A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.一种人源化治疗性CD4单克隆抗体可抑制TCR诱导的IL-2、IL-4和IL-10分泌以及CD25、CD40L和CD69的表达。
Cell Immunol. 1998 May 1;185(2):101-13. doi: 10.1006/cimm.1998.1287.
5
Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.共刺激信号调节可提高T细胞中cAMP水平的药物的抗增殖作用。
Cell Immunol. 1994 Oct 1;158(1):116-30. doi: 10.1006/cimm.1994.1261.
6
Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.静止人类T细胞上CD5或CD28分子的结扎通过钙和酪氨酸激酶依赖性机制诱导早期激活抗原CD69的表达。
Immunology. 1993 Feb;78(2):210-7.
7
Signal transduction by B7/BB1 expressed on activated T lymphocytes: cross-linking of B7/BB1 induces protein tyrosine phosphorylation and synergizes with signalling through T-cell receptor/CD3.活化T淋巴细胞上表达的B7/BB1的信号转导:B7/BB1的交联诱导蛋白酪氨酸磷酸化,并与通过T细胞受体/CD3的信号传导协同作用。
Immunology. 1995 Oct;86(2):155-61.
8
CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma.在基于双特异性单克隆抗体的卵巢癌治疗中,CD3-CD28共刺激作为一种避免T细胞预激活的手段。
Cancer Res. 1996 Dec 1;56(23):5443-9.
9
CD28-mediated activation of resting human T cells without costimulation of the CD3/TCR complex.CD28介导的静息人T细胞活化,无需CD3/TCR复合物的共刺激。
Cell Immunol. 1997 Feb 25;176(1):59-65. doi: 10.1006/cimm.1996.1066.
10
Cooperation between an anti-T cell (anti-CD28) monoclonal antibody and monocyte-produced IL-6 in the induction of T cell responsiveness to IL-2.抗T细胞(抗CD28)单克隆抗体与单核细胞产生的白细胞介素-6在诱导T细胞对白细胞介素-2反应性中的协同作用。
J Immunol. 1988 Sep 1;141(5):1502-7.

引用本文的文献

1
CD47: The Next Frontier in Immune Checkpoint Blockade for Non-Small Cell Lung Cancer.CD47:非小细胞肺癌免疫检查点阻断的新前沿
Cancers (Basel). 2023 Oct 31;15(21):5229. doi: 10.3390/cancers15215229.
2
CD47 expression is critical for CAR T-cell survival in vivo.CD47 表达对于 CAR T 细胞在体内的存活至关重要。
J Immunother Cancer. 2023 Mar;11(3). doi: 10.1136/jitc-2022-005857.
3
AL008 Enhances Myeloid Antitumor Function by Inhibiting SIRPα Signaling and Activating Fc Receptors.AL008 通过抑制 SIRPα 信号和激活 Fc 受体增强髓系抗肿瘤功能。
J Immunol. 2023 Jan 15;210(2):204-215. doi: 10.4049/jimmunol.2200157.
4
CD47 (Cluster of differentiation 47): an anti-phagocytic receptor with a multitude of signaling functions.CD47(分化簇47):一种具有多种信号传导功能的抗吞噬受体。
Anim Cells Syst (Seoul). 2020 Sep 15;24(5):243-252. doi: 10.1080/19768354.2020.1818618.
5
Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα-CD47 innate immune checkpoint.ADU-1805 是一种选择性的全等位基因抗 SIRPα 抗体,可阻断 SIRPα-CD47 固有免疫检查点,对其功能进行了鉴定。
J Immunother Cancer. 2019 Dec 4;7(1):340. doi: 10.1186/s40425-019-0772-0.
6
Overexpression of PDE4A Acts as Checkpoint Inhibitor Against cAMP-Mediated Immunosuppression .PDE4A 过表达可作为 cAMP 介导免疫抑制的检查点抑制剂
Front Immunol. 2019 Jul 30;10:1790. doi: 10.3389/fimmu.2019.01790. eCollection 2019.
7
Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells.双重阻断 PD-L1 和 CD47 可增强对循环肿瘤细胞的免疫治疗作用。
Sci Rep. 2019 Mar 14;9(1):4532. doi: 10.1038/s41598-019-40241-1.
8
CRISPR/Cas9-mediated knockout of causes hemolytic anemia with splenomegaly in C57BL/6 mice.CRISPR/Cas9介导的基因敲除导致C57BL/6小鼠出现溶血性贫血并伴有脾肿大。
Lab Anim Res. 2018 Dec;34(4):302-310. doi: 10.5625/lar.2018.34.4.302. Epub 2018 Dec 31.
9
MYC regulates the antitumor immune response through CD47 and PD-L1.MYC 通过 CD47 和程序性死亡受体配体 1(PD-L1)调节抗肿瘤免疫反应。
Science. 2016 Apr 8;352(6282):227-31. doi: 10.1126/science.aac9935. Epub 2016 Mar 10.
10
CD47: a potential immunotherapy target for eliminating cancer cells.CD47:一种用于清除癌细胞的潜在免疫治疗靶点。
Clin Transl Oncol. 2016 Nov;18(11):1051-1055. doi: 10.1007/s12094-016-1489-x. Epub 2016 Feb 1.